Clinical trial
The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on…
NCT00012506 · National Eye Institute (NEI), NIH · Unknown status
Key facts
| NCT number | NCT00012506 |
|---|---|
| Title | The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Uveitis, Arthritis, Juvenile Rheumatoid |
| Intervention type | Drug |
| Interventions | TNFR:Fc |
| First posted | Mar 12, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: